Kunal Sampat joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the changing landscape of clinical trial operations. An experienced Clinical Operations Director, Kunal shares his key learnings from 2020 and elaborates on some of the successes and challenges he’s seen this year. Industry stakeholders
Most, if not all, industry events have gone virtual in 2020. Clinical Innovations Summit is the most recent one to convert to an online setting, and it's now combined with SCOPE Europe, usually held in beautiful Barcelona, Spain.
The ArcheMedX team is excited to be a cornerstone of this year's Clinical
ArcheMedX today announced its on-going collaboration with PRA Health Sciences in a highly anticipated joint case study at the 2020 Clinical Trial Innovations Summit.
On Wednesday, 11 November, Kelly Ritch, EVP of Product and Clinical Solutions at ArcheMedX, will join Susan Zakarian, Sr. Manager of PRA Health Sciences to co-present a
We’ve talked about clinical trial readiness repeatedly in this space. Probably we all, as an industry, have a good sense of what that means — or what it used to mean. The definition has acquired a whole new dimension in recent days. For example, this post was originally planned to be about a theoretical subset of sites
We recently spoke with Kevin M. Crawford, head of clinical operations at Tenax Therapeutics, a specialty pharmaceutical company based in Morrisville, North Carolina, that focuses on identifying, developing, and commercializing products to address cardiovascular and pulmonary diseases. We wanted to share these excerpts from the conversation:
You’ve talked about the importance of telling your story. Can you expound on that?
At Tenax therapeutics, we're
The threat of Coronavirus (COVID-19) is real and spreading. The most vulnerable among us (the elderly, immunocomprised individuals, and those with underlying health conditions) are at high risk of suffering from this virus. Public health experts and the CDC are urging more extreme social distancing, yet too many of us